ICU
Price
$0.65
Change
-$0.04 (-5.80%)
Updated
Oct 3 closing price
Capitalization
18.11M
MBRX
Price
$0.46
Change
-$0.04 (-8.00%)
Updated
Oct 3 closing price
Capitalization
22.85M
Interact to see
Advertisement

ICU vs MBRX

Header iconICU vs MBRX Comparison
Open Charts ICU vs MBRXBanner chart's image
SeaStar Medical Holding
Price$0.65
Change-$0.04 (-5.80%)
Volume$2.54M
Capitalization18.11M
Moleculin Biotech
Price$0.46
Change-$0.04 (-8.00%)
Volume$4.07M
Capitalization22.85M
ICU vs MBRX Comparison Chart in %
ICU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICU vs. MBRX commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICU is a Buy and MBRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (ICU: $0.65 vs. MBRX: $0.46)
Brand notoriety: ICU and MBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICU: 104% vs. MBRX: 120%
Market capitalization -- ICU: $18.11M vs. MBRX: $22.85M
ICU [@Biotechnology] is valued at $18.11M. MBRX’s [@Biotechnology] market capitalization is $22.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICU’s FA Score shows that 0 FA rating(s) are green whileMBRX’s FA Score has 0 green FA rating(s).

  • ICU’s FA Score: 0 green, 5 red.
  • MBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ICU is a better buy in the long-term than MBRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICU’s TA Score shows that 4 TA indicator(s) are bullish while MBRX’s TA Score has 3 bullish TA indicator(s).

  • ICU’s TA Score: 4 bullish, 6 bearish.
  • MBRX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ICU is a better buy in the short-term than MBRX.

Price Growth

ICU (@Biotechnology) experienced а +7.71% price change this week, while MBRX (@Biotechnology) price change was -6.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBRX($22.9M) has a higher market cap than ICU($18.1M). ICU YTD gains are higher at: -66.567 vs. MBRX (-72.841). ICU has higher annual earnings (EBITDA): -14.63M vs. MBRX (-25.32M). MBRX has more cash in the bank: 7.56M vs. ICU (6.3M). ICU has less debt than MBRX: ICU (363K) vs MBRX (420K). ICU has higher revenues than MBRX: ICU (766K) vs MBRX (0).
ICUMBRXICU / MBRX
Capitalization18.1M22.9M79%
EBITDA-14.63M-25.32M58%
Gain YTD-66.567-72.84191%
P/E RatioN/AN/A-
Revenue766K0-
Total Cash6.3M7.56M83%
Total Debt363K420K86%
FUNDAMENTALS RATINGS
MBRX: Fundamental Ratings
MBRX
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ICUMBRX
RSI
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
65%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
58%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
49%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
38%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ICU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZBIO21.760.81
+3.87%
Zenas Biopharma Inc.
VSTD1.550.04
+2.65%
Vestand Inc
EXC45.340.37
+0.82%
Exelon Corp
ENS114.75-0.27
-0.23%
EnerSys
NIPG1.73-0.07
-3.72%
NIP Group Inc

ICU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICU has been closely correlated with TNXP. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICU jumps, then TNXP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICU
1D Price
Change %
ICU100%
-5.31%
TNXP - ICU
77%
Closely correlated
-2.91%
UNCY - ICU
46%
Loosely correlated
N/A
CRIS - ICU
27%
Poorly correlated
+2.48%
MBRX - ICU
27%
Poorly correlated
-7.66%
PROK - ICU
25%
Poorly correlated
-1.44%
More

MBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBRX has been loosely correlated with EDSA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if MBRX jumps, then EDSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBRX
1D Price
Change %
MBRX100%
-7.66%
EDSA - MBRX
34%
Loosely correlated
-6.91%
AMRN - MBRX
32%
Poorly correlated
+12.54%
UNCY - MBRX
31%
Poorly correlated
N/A
AXON - MBRX
29%
Poorly correlated
-0.70%
VKTX - MBRX
29%
Poorly correlated
+6.60%
More